Skip to content

How to get more Sculptra patients: a plan for practices

A front desk team member at a med spa and aesthetic clinic handles a new patient call

Sculptra (injectable poly-L-lactic acid) is a cash-pay injectable, and its FDA labeling says a lot about how it should be described. This guide is for practice owners, patient coordinators and front desk teams: what the labeling covers, which claims to avoid, and how to answer first calls so requests become booked consultations.

  1. SearchAn adult looks for care near them.
  2. Your pageWhat you treat, who sees them, one way to book.
  3. Call or formThey call or send a request.
  4. Front deskBooks the visit and never guesses a cause.
  5. Clinical teamThe clinician decides the plan.
How a new patient request reaches your practice.

1. Know what the device is approved for

Sculptra is approved under PMA P030050. FDA’s PMA database shows the 2004 approval for facial fat loss in people with HIV, Sculptra Aesthetic for facial wrinkles in 2009 (S002), a single trade name in 2021 (S034) and cheek wrinkles in 2023 (S039). The clinician labeling says Sculptra is indicated for “correction of shallow to deep nasolabial fold contour deficiencies and other facial wrinkles” and “correction of fine lines and wrinkles in the cheek region” in immune-competent subjects.

  • Describe the service as treatment for facial wrinkles and folds, including cheek lines.
  • Do not advertise it for lips, under the eyes or the body. The labeling says it “should not be injected into the red area (vermillion) of the lips” and periorbital injection “has not been studied”. FDA’s dermal fillers page recommends against fillers for body contouring, including the breasts and buttocks.
  • This is a PMA device, so “FDA approved” is the right term for its approved indications only. See FDA approved vs FDA cleared.

2. Keep claims in line with the labeling

The labeling gives concrete facts to work with:

  • Results are gradual. The patient guide says Sculptra “provides a gradual improvement of the depressed area over several weeks”. Early fullness is swelling that typically resolves within a few days.
  • It is a series. Use is limited to “a single regimen of up to four sequential sessions each spaced three to four-weeks apart”; the patient guide says typically three.
  • Side effects are common. In the cheek study, the most common symptoms were tenderness (93.5%), bruising (93.5%), swelling (87.1%) and pain (83.9%).
  • Delayed lumps can occur. The labeling warns of papules and nodules “occurring days to months after injection”; in the post-approval study 28.4% of subjects had them. Rare injection into a blood vessel can cause vision loss, stroke or skin necrosis.

So avoid “instant results”, “one session”, “no side effects”, “risk-free” and set durations. The patient guide says the body “may” produce new collagen, so do not promise it. Better wording: “results build gradually over several weeks” and “your injector will explain the risks and aftercare”. Do not promise a set result.

3. Answer first-call questions honestly

  • How much does it cost? Give a clear price per session and say several sessions are usual, rather than quoting one session as the total.
  • Will I see results right away? “No. Results build gradually over several weeks, and early fullness is mostly swelling that goes down.”
  • How many sessions will I need? “The injector will plan it, usually up to four sessions a few weeks apart.”
  • Can you use it on my lips or buttocks? “It is approved for facial wrinkles and folds, including cheek lines.”

Leave medical screening to the injector. The patient guide lists severe allergies, keloids or hypertrophic scarring, pregnancy or breastfeeding, immunosuppressants, bleeding disorders or blood thinners, and recent laser treatment or peels. Your intake form should ask; the injector decides. Use the new patient phone script for the rest of the call.

4. Book the series, not just the first visit

The labeling recommends three to four weeks between sessions for nasolabial folds, at least three for other facial wrinkles and at least four for cheek lines. When the injector plans a series, offer the next dates before the patient leaves. Mention aftercare, such as massaging the area “for 5 minutes 5 times per day for 5 days”, and give patients a number to call about unusual pain, vision changes or skin whitening.

5. Price, package and follow up

Where MediLeadGen fits

MediLeadGen sends practices requests from people interested in cash-pay elective treatments. Each request goes to one practice only, with the person’s consent naming that practice, at a fixed price per delivered request.

See how it works for practices

Questions practices ask

How do we get more Sculptra patients?

Answer requests quickly, give a clear price per session and say several sessions are usual, explain gradual results and side effects honestly, keep claims in line with the labeling, and book a consultation where the injector can plan the series.

What is Sculptra approved for?

Its labeling says it is indicated for shallow to deep nasolabial fold contour deficiencies and other facial wrinkles, and for fine lines and wrinkles in the cheek region, in immune-competent people, and for facial fat loss in people with HIV. It should not be injected into the red area of the lips.

Can we advertise instant results?

Avoid it. The labeling says improvement is gradual over several weeks, and early fullness after a session is mostly swelling that typically resolves within hours to a few days.

Is Sculptra one session?

Usually not. The labeling describes up to four sessions spaced three to four weeks apart, typically three, so quote prices per session and let the injector set the plan.

General information for practice teams, not legal or clinical advice. Check the labeling of the products you use, state rules and your advertising with counsel and your clinicians. Last reviewed October 2026.

More resources

All resources for practices